These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8951128)

  • 21. Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence.
    Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Meadows ES; Yalcin I; Muram D;
    Obstet Gynecol; 2005 Oct; 106(4):767-73. PubMed ID: 16199634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunctional voiding in women.
    Carlson KV; Rome S; Nitti VW
    J Urol; 2001 Jan; 165(1):143-7; discussion 147-8. PubMed ID: 11125384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of sensation-related voiding patterns between continent and incontinent women: a study with a 3-day sensation-related bladder diary (SR-BD).
    Naoemova I; De Wachter S; Wyndaele JJ
    Neurourol Urodyn; 2008; 27(6):511-4. PubMed ID: 18092332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.
    Haab F; Stewart L; Dwyer P
    Eur Urol; 2004 Apr; 45(4):420-9; discussion 429. PubMed ID: 15041104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    van der Pal F; van Balken MR; Heesakkers JP; Debruyne FM; Bemelmans BL
    BJU Int; 2006 Mar; 97(3):547-50. PubMed ID: 16469023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendations for the use of voiding diaries and symptom or quality of life questionnaires in the investigation of non-neurological female urinary incontinence].
    Le Normand L;
    Prog Urol; 2007 Nov; 17(6 Suppl 2):1252-63. PubMed ID: 18214137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between urinary symptom questionnaires and urodynamic diagnoses: an analysis of two methods of questionnaire administration.
    Khan MS; Chaliha C; Leskova L; Khullar V
    BJOG; 2004 May; 111(5):468-74. PubMed ID: 15104612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder diary measurements in asymptomatic males: frequency, volume per void, and 24-hr volume.
    Tissot W; Amundsen CL; Diokno AC; Webster GD; Coats AC;
    Neurourol Urodyn; 2008; 27(3):198-204. PubMed ID: 17638309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
    Unsal A; Cimentepe E
    Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-assessment of fluid intake behavior in women with urinary incontinence.
    Segal S; Saks EK; Arya LA
    J Womens Health (Larchmt); 2011 Dec; 20(12):1917-21. PubMed ID: 21970566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of routine evaluation of the voiding phase when performing urodynamic testing in women with lower urinary tract symptoms.
    Carlson KV; Fiske J; Nitti VW
    J Urol; 2000 Nov; 164(5):1614-8. PubMed ID: 11025717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
    Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD;
    J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation of dose titration with darifenacin, an M3-selective receptor antagonist.
    Steers W; Corcos J; Foote J; Kralidis G
    BJU Int; 2005 Mar; 95(4):580-6. PubMed ID: 15705084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a validated urinary diary: phase 1.
    Bright E; Cotterill N; Drake M; Abrams P
    Neurourol Urodyn; 2012 Jun; 31(5):625-33. PubMed ID: 22275270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].
    Hermieu JF;
    Prog Urol; 2007 Nov; 17(6 Suppl 2):1264-84. PubMed ID: 18214138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validating the incontinence symptom severity index: a self-assessment instrument for voiding symptom severity in women.
    Twiss C; Triaca V; Anger J; Patel M; Smith A; Kim JH; Raz S; Rodríguez LV
    J Urol; 2009 Nov; 182(5):2384-91. PubMed ID: 19758631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of daytime diuresis on voiding frequency and incontinence classification in children.
    Mahler B; Hagstroem S; Rittig N; Mikkelsen MM; Rittig S; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2384-8. PubMed ID: 18433779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and testing of a new instrument to measure fluid intake, output, and urinary symptoms: the questionnaire-based voiding diary.
    Arya LA; Banks C; Gopal M; Northington GM
    Am J Obstet Gynecol; 2008 May; 198(5):559.e1-7. PubMed ID: 18455534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in 24-hour urinary diaries of asymptomatic North American adults.
    Mueller E; Latini J; Lux M; Stablein U; Brubaker L; Kreder K; Fitzgerald MP
    J Urol; 2005 Feb; 173(2):490-2. PubMed ID: 15643226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-reported urinary incontinence, voiding frequency, voided volume and pad-test results: variables in a prospective study in children.
    Bael AM; Lax H; Hirche H; Gäbel E; Winkler P; Hellström AL; van Zon R; Janhsen E; Güntek S; Renson C; van Gool JD;
    BJU Int; 2007 Sep; 100(3):651-6. PubMed ID: 17488303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.